Panelists discuss how payers can evaluate BTK inhibitors by considering specific MS phenotypes and FDA indications rather ...

Columnist Desiree Lama explores how living with MS led her to confront the comparison trap, ultimately finding strength in ...

Panelists discuss how BTK inhibitors represent a promising new oral therapy class that could address both inflammatory and ...

Although MS is classified as an immune-mediated disease, that doesn’t automatically imply that it’s an autoimmune disease.In fact, research on the topic is relatively mixed, with some experts ...

Ms Harris has consistently served as a critical messenger since the US Supreme Court’s Dobbs decision in 2022, which let states set their own laws on abortion, including complete bans.